Arcadia Biosciences(RKDA) - 2025 Q2 - Quarterly Results

Exhibit 99.2 Arcadia Biosciences, Inc. Consolidated Balance Sheets (Unaudited) (In thousands) | | | | Six Months Ended June 30, | | | --- | --- | --- | --- | --- | | | | 2025 | | 2024 | | CASH FLOWS FROM OPERATING ACTIVITIES: | | | | | | Net loss | $ | (1,859) | $ | (1,362) | | Adjustments to reconcile net loss to cash used in operating activities: | | | | | | Change in fair value of common stock warrant and option liabilities | | (1,314) | | (163) | | Change in fair value of contingent consideration | | (2 ...